May 01, 2008 - Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, announced the signing of a definitive merger agreement.
Cornerstone is a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders... Critical Therapeutics' Press Release - Cornerstone BioPharma's Press Release -
